New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...

Objective: To investigate the association between cardiovascular health (CVH) and obstructive sleep apnea (OSA) within the U.S. population. Methods: This study enrolled 12,540 participants aged 20 ...

Sleep disordered breathing is a range of conditions that cause abnormal breathing during sleep, including snoring and obstructive sleep apnea. Obstructive sleep apnea is when a person stops ...

Various medical devices are available to help treat sleep apnea. Choosing the right one comes down to the severity of your condition, your personal preferences, and your lifestyle. Sleep apnea is ...

Background: The Dietary Approaches to Stop Hypertension (DASH) are associated with reduced cardiovascular, diabetes risk, but the effect on obstructive sleep apnea (OSA) is uncertain. Methods: This ...